Exostar’s Life Sciences Cloud Collaboration Platform Exceeds Growth Objectives
News Feb 21, 2014
Exostar, whose cloud-based solutions enable secure, cost-effective business-to-business collaboration, has announced significant milestones in the adoption of its community cloud access and collaboration service offering for the Life Sciences industry. Led by two of the ten largest global pharmaceutical companies, more than 500 organizations supporting over 10,000 individuals in 46 countries on six continents are leveraging Exostar’s Life Sciences Identity Hub and Secure Access Manager (SAM) to safely, securely, and cost-effectively collaborate in the cloud.
Exostar’s solutions are an enabler that supports the transformation of the drug research and development (R&D) process. Rather than go it alone, companies are embracing a partner-centric R&D model that speeds time-to-market for new drugs and therapies. Exostar’s community offering in the cloud addresses three key business tenets:
Connect once (to access applications across enterprise boundaries)
Collect once (to share partner attribute information with relying parties)
Certify once (to reduce the cost of multiple audits)
The Exostar Life Sciences Identity Hub brings together organizations and their systems, applications, and information. The cloud-based Identity Hub, delivered as-a-Service, eliminates the need for companies including manufacturers, clinical research organizations, and academic institutions to establish and maintain costly, redundant point-to-point interactions, freeing critical IT resources and budgets.
SAM provides employees of connected organizations with single sign-on access, using their existing credentials, to a growing list of more than 20 enterprise-class applications both on-premise and in the cloud. SAM controls user access through strong authentication of identities, along with enforcement of the roles and privileges assigned and updated by system, application, and information owners.
Exostar teams with stakeholders in the community to define and refine the Life Science Identity Hub’s processes, rules, and governance terms that provide the flexibility and accountability necessary to ensure compliance with corporate, industry, and Government regulatory requirements, while protecting intellectual property and sensitive information from compromise. The Life Sciences service offering builds on Exostar’s expertise in delivering similar capabilities to the Aerospace and Defense marketplace, where the community encompasses nearly 100,000 organizations and 300,000 users in 150 countries.
“Our solution is allowing Life Sciences organizations to more quickly establish new relationships, strengthen existing relationships, and reduce IT costs,” said Vijay Takanti, Exostar’s Vice President of Security and Collaboration Solutions. “By reducing the time it takes these organizations to begin collaborating productively with their external partners from months to days, we are helping streamline the drug R&D process – driving new revenue streams for our customers while bringing life-altering drugs and therapies to market sooner.”
Algorithm Speeds Up Medical Image Analysis 1000 TimesNews
Medical image registration is a common technique that involves overlaying two images, such as magnetic resonance imaging (MRI) scans, to compare and analyze anatomical differences in great detail. Researchers have described a machine-learning algorithm that can register brain scans and other 3-D images more than 1,000 times more quickly using novel learning techniques.
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.
Towards Personalized Medicine: One Type of Data is Not EnoughNews
To understand the biology of diseased organs researchers use different types of molecular data. One of the biggest computational challenges at the moment is integrating these multiple data types. A new computational method jointly analyses different types of molecular data and disentangles the sources of disease variability to guide personalized treatment.READ MORE